logo
Select company
Select metric
-78.14%Return on Assets
VS
Market
9
Sector
28
Industry
37
History
7
$ 3.7Close
$ 0.88 - $ 4.74 52-Week Range
Ticker Information

Ticker

PYXS

Company Name

PYXIS ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PYXIS ONCOLOGY INC - Return on Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PYXS - ROA Historical data
DateTotal AssetsNet Income Common StockReturn on Assets
6/30/2025$ 123.22M$ -96.29M-78.14%
3/31/2025$ 135.87M$ -95.23M-70.09%
12/31/2024$ 157.18M$ -77.33M-49.2%
9/30/2024$ 195.31M$ -57.36M-29.37%
6/30/2024$ 208.39M$ -59.2M-28.41%
3/31/2024$ 220.22M$ -57.8M-26.25%
12/31/2023$ 173.73M$ -73.79M-42.47%
9/30/2023$ 186.69M$ -94.29M-50.51%
6/30/2023$ 175.23M$ -98.92M-56.45%
3/31/2023$ 182.8M$ -108.58M-59.4%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PYXIS ONCOLOGY INC's latest trailing twelve months (TTM) ROA stands at -126.37%.
  • Over the past 5 years, PYXIS ONCOLOGY INC's average ROA has been -52.16%.
  • The median ROA for PYXIS ONCOLOGY INC during this period was -49.2%
  • PYXIS ONCOLOGY INC reached its highest ROA over the past 5 years at -26.25%.
  • The lowest ROA recorded by PYXIS ONCOLOGY INC in the same timeframe -126.37%

PYXIS ONCOLOGY INC's ROA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROA Benchmarks
CompanyROA
NTRB : NUTRIBAND INC -315.26%ALGS : ALIGOS THERAPEUTICS INC -55.07%STTK : SHATTUCK LABS INC -95.56%ORMP : ORAMED PHARMACEUTICALS INC -14.98%CAMP : CAMP4 THERAPEUTICS CORP -100.99%ARMP : ARMATA PHARMACEUTICALS INC -31.82%DTIL : PRECISION BIOSCIENCES INC -71.84%NRXS : NEURAXIS INC -110.11%CBUS : CIBUS INC -79.53%ABVC : ABVC BIOPHARMA INC -18.82%

Definition of Return on Assets

[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
Net Inc. Cmn. / Assets
(=) ROA
ROA for PYXIS ONCOLOGY INC is calculated as follows: Net Inc. Cmn. [ $ -12.83M ] / Assets [ $ 10.15M ]
(=) ROA [ -126.37% ]

PYXS - Return on Assets, Last 5 years

-126.37%

Minimum

Dec 31, 2020

-26.25%

Maximum

Mar 31, 2024

-52.16%

Average

-49.2%

Median

ROA Benchmark Analysis

The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.12% with a standard deviation of 10.61%.
The following table provides additional summary stats:
ROA in the Market:
filtered constituents3.44K
min-33.4%
max33.98%
average0.12%
median1.53%
std10.61%